News Tag: English
-
Ortivus is granted market approval for MobiMed Monitor in Australia
Ortivus expands prehospital care capabilities in Australia together with Trapeze Group
-
Ortivus AB (publ) interim report for the period January – March 2022
Ortivus expands
-
Ortivus communicates a growth target of 15% annually
Ortivus’ goal is to reach an organic growth of an average of 15% annually while maintaining profitability, to achieve at least 25 MSEK profit within 4 years. Ortivus aims to increase sales to existing customers, gain additional market shares and reach new geographical markets in the prehospital and primary care segment.
-
Ortivus is granted market approval of MobiMed in New Zealand.
Ortivus is now permitted to advertise and sell MobiMed in the New Zealand market.